NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Continuous Glucose Monitoring (CGM) After Kidney Transplantation
Continuous Glucose Monitoring (CGM) After Kidney Transplantation

NCT06675903

RecruitingN/A

Sponsor: Bo Feldt-Rasmussen

Conditions: Hyperglycaemia, Kidney Transplantation

Countries: Denmark

This study examines glucose levels measured by continuous glucose monitoring (CGM) in the immediate period following kidney transplantation among recipients with diabetes, without diabetes, and with pre-diabetes. The primary objective is to analyse differences in mean sensor glucose between these three groups. CGMs are applied to participants within 72 hours after kidney transplantation, with a total of 54 participants divided equally across the three groups (18 in each). Secondary objectives include assessing additional glucose profile indices, adherence to relevant guidelines, changes in HbA1c, the impact of immunosuppression and steroid dosage, and beta cell function.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Written informed consent obtained before CGM application
* Male or female; age: ≥18 years
* Kidney transplantation

Exclusion Criteria:

* Unable to cooperate to CGM the first ten days after surgery
* Allergic to plasters in CGM units
* Combined kidney and liver or pancreatic transplantation
* Graft loss/rejection within first 48 hours after transplantation
Locations (1)
  • Copenhagen, DK, Denmark